The vaccine that helps prevent children from contracting Hib (Haemophilus influenza type b), diphtheria, whopping cough, tetanus and hepatitis b, has fallen 22% in cost due to the demand and need by developing countries. This shot is routinely given to children in developed countries, however the high prices have left millions of children in developing countries out of reach of the vaccination. The recent drop in price was $.50 per dose, which will lead to $55 million dollars in savings for GAVI in 20120. GAVI buys and distributes vaccinations to developing countries. They said that this drop in price is due to the higher demand, the industry understands the markets regardless if it is rich or poor. The projected amount of doses that they will now be able to buy of this vaccine will go from 50 million in 2009 to 120 million in 2010.
-Sara Frodge
Source: Reuters India
Posts
